Showing results (61-70 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|October 23, 2021
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H B M Schreuder, Koen M van Nieuwenhuizen, Jeannette Hofmeijer, et al.
The Lancet. Neurology|October 23, 2021
Alzheimer's disease associated with Down syndrome: a genetic form of dementiaJuan Fortea, Shahid H Zaman, Sigan Hartley, et al.
The Lancet. Neurology|February 19, 2022
Management of atherosclerotic extracranial carotid artery stenosisLeo H Bonati, Olav Jansen, Gert J de Borst, et al.
The Lancet. Neurology|March 1, 2022
Spontaneous intracranial hypotension: searching for the CSF leakTomas Dobrocky, Patrick Nicholson, Levin Häni, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
The Lancet. Neurology|January 22, 2022
Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disordersMaartje G Huijbers, Alexander Marx, Jaap J Plomp, et al.
The Lancet. Neurology|July 10, 2019
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Michelle Mellion, Raymond Hupperts, et al.
The Lancet. Neurology|March 25, 2022
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosisStephen A Goutman, Orla Hardiman, Ammar Al-Chalabi, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
The Lancet. Neurology|February 26, 2011
Paediatric stroke: genetic insights into disease mechanisms and treatment targetsPinki Munot, Yanick J Crow, Vijeya Ganesan
Pageof 199